ZA859428B - Biological preparations - Google Patents

Biological preparations

Info

Publication number
ZA859428B
ZA859428B ZA859428A ZA859428A ZA859428B ZA 859428 B ZA859428 B ZA 859428B ZA 859428 A ZA859428 A ZA 859428A ZA 859428 A ZA859428 A ZA 859428A ZA 859428 B ZA859428 B ZA 859428B
Authority
ZA
South Africa
Prior art keywords
vaccine
infectious bronchitis
live
priming
strain
Prior art date
Application number
ZA859428A
Other languages
English (en)
Inventor
Philip George Box
Harvey Charles Holmes
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10571022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA859428(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA859428B publication Critical patent/ZA859428B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA859428A 1984-12-11 1985-12-10 Biological preparations ZA859428B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848431253A GB8431253D0 (en) 1984-12-11 1984-12-11 Biological preparations

Publications (1)

Publication Number Publication Date
ZA859428B true ZA859428B (en) 1987-08-26

Family

ID=10571022

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859428A ZA859428B (en) 1984-12-11 1985-12-10 Biological preparations

Country Status (7)

Country Link
EP (1) EP0186368B1 (fr)
AT (1) ATE62134T1 (fr)
DE (1) DE3582422D1 (fr)
DK (1) DK170923B1 (fr)
GB (1) GB8431253D0 (fr)
IE (1) IE58822B1 (fr)
ZA (1) ZA859428B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707168B1 (fr) * 1993-07-08 1995-08-18 Rhone Merieux Vaccin contre la dysenterie hémorragique du porc et ensemble de vaccination y relatif.
ES2152292T3 (es) * 1993-07-30 2001-02-01 Akzo Nobel Nv Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
WO2001009290A2 (fr) * 1999-07-30 2001-02-08 Laboratorio Avi-Mex, S.A. De C.V. Serotype du virus de bronchite infectieuse aviaire

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines

Also Published As

Publication number Publication date
GB8431253D0 (en) 1985-01-23
DK170923B1 (da) 1996-03-18
ATE62134T1 (de) 1991-04-15
EP0186368A2 (fr) 1986-07-02
IE853109L (en) 1986-06-11
DE3582422D1 (de) 1991-05-08
EP0186368A3 (en) 1987-02-04
DK569985D0 (da) 1985-12-10
EP0186368B1 (fr) 1991-04-03
IE58822B1 (en) 1993-11-17
DK569985A (da) 1986-06-12

Similar Documents

Publication Publication Date Title
CA2031164A1 (fr) Herpesvirus recombinant de dindons et vaccins de vecteur vivant qui en sont derives
HK166295A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
HUT65367A (en) Method for the preparation of chicken anaemia agent vaccine
IL100010A0 (en) Avirulent strain of salmonella typhi,its preparation and vaccines containing it
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
GB8431253D0 (en) Biological preparations
EP0626008A4 (en) Vaccine containing acemannan as an adjuvant.
EP0513921A3 (en) Recombinant vaccine against marek's disease
NZ243251A (en) Vaccine against marek's disease virus in poultry
DE2965191D1 (en) Herpes virus vaccine and its preparation
Saint-Gérand Towards a second generation of inactivated vaccines: Use of herpesvirus (feline rhinotracheitis virus) subunits for the prevention of cat flu
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
Rethy Experimental-epidemiological studies on the immunological interactions between live and/or killed virus vaccines applied simultaneously with inactivated monovalent or combined vaccines. Survey of human results achieved between 1960-1978.
Joklik Antigenic relationships between the proteins of the three serotypes of reovirus.
Wasinski et al. Effect of antibiotics on the immune response of pigs against erysipelas suum vaccinated against swine fever, erysipelas and colibacillosis.